Get started
Author

Rodolfo Garza Morales

Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study
2024 · Taylor R. Brooks, Emily C. Zabor, et al. · Blood · 15
Oral selective estrogen receptor degraders in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis
2026 · Lorrany Larisse Costa Rodrigues, Lara de Holanda Jucá Silveira, et al. · Breast Cancer Research and Treatment · 2
Outcomes following disease progression after epcoritamab or glofitamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study
2025 · Taylor Brooks, Agrima Mian, et al. · Blood · 1
Risk factors for cytokine release syndrome and neurotoxicity in patients receiving epcoritamab or glofitamab for large B cell lymphoma: A multi-center, retrospective, real world analysis.
2025 · XI Yang, Yasmin Karimi, et al. · Blood · 1
PDF
Comparative health-related quality of life (QoL) in metastatic castration-sensitive prostate cancer (mCSPC): A living systematic review.
2024 · Rodolfo Garza Morales, Syed Arsalan Ahmed Naqvi, et al. · Journal of Clinical Oncology
Clinical trial enrollment in a Hispanic-majority NCI-designated cancer center: The Mays Cancer Center experience over 10 years.
2023 · Rodolfo Garza Morales, Anand B. Karnad, et al. · Journal of Clinical Oncology
PDF
Ethnicity Matters When Comparing Overall Survival for Patients Diagnosed with Follicular Lymphoma
2021 · Carolina Velez-Mejia, Rodolfo Garza Morales, et al. · Blood
Vacunas terapéuticas contra el VPH: envío de antígenos al retículo endoplásmico
2016 · José Juan Pérez Trujillo, Gabriel Figueroa Parra, et al.
Simulación De La Distribución De Tubería Ligera En México
2012 · Rodolfo Garza Morales, Miguel Mata Pérez, et al.
Works count: 9
Citation count: 19
H-index: 2
I10-index: 1
Year
Topic
Type